SQZ Biotechnologies (SQZ) Competitors $0.03 0.00 (0.00%) As of 09/17/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock SQZ vs. CISS, OP, GVH, USDP, AIRTP, BLDEW, RA, EDRY, HSHP, and IMPPPShould you be buying SQZ Biotechnologies stock or one of its competitors? The main competitors of SQZ Biotechnologies include C3is (CISS), OceanPal (OP), Globavend (GVH), USD Partners (USDP), Air T (AIRTP), Blade Air Mobility (BLDEW), Brookfield Real Assets Income Fund (RA), EuroDry (EDRY), Himalaya Shipping (HSHP), and Imperial Petroleum (IMPPP). These companies are all part of the "transportation" industry. SQZ Biotechnologies vs. Its Competitors C3is OceanPal Globavend USD Partners Air T Blade Air Mobility Brookfield Real Assets Income Fund EuroDry Himalaya Shipping Imperial Petroleum C3is (NASDAQ:CISS) and SQZ Biotechnologies (NYSE:SQZ) are both small-cap transportation companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, analyst recommendations, media sentiment, risk, earnings and profitability. Do institutionals and insiders believe in CISS or SQZ? 10.5% of C3is shares are owned by institutional investors. Comparatively, 38.5% of SQZ Biotechnologies shares are owned by institutional investors. 16.0% of SQZ Biotechnologies shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Does the media refer more to CISS or SQZ? In the previous week, C3is' average media sentiment score of 0.00 equaled SQZ Biotechnologies'average media sentiment score. Company Overall Sentiment C3is Neutral SQZ Biotechnologies Neutral Is CISS or SQZ more profitable? C3is has a net margin of 20.51% compared to SQZ Biotechnologies' net margin of -369.96%. C3is' return on equity of 5.41% beat SQZ Biotechnologies' return on equity.Company Net Margins Return on Equity Return on Assets C3is20.51% 5.41% 4.07% SQZ Biotechnologies -369.96%-119.83%-59.90% Which has higher valuation and earnings, CISS or SQZ? C3is has higher revenue and earnings than SQZ Biotechnologies. C3is is trading at a lower price-to-earnings ratio than SQZ Biotechnologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioC3is$42.30M0.05-$2.75M-$18.04-0.13SQZ Biotechnologies$18.16M0.05-$79.46M-$2.61-0.01 Which has more volatility & risk, CISS or SQZ? C3is has a beta of 1.7, meaning that its stock price is 70% more volatile than the S&P 500. Comparatively, SQZ Biotechnologies has a beta of 2.34, meaning that its stock price is 134% more volatile than the S&P 500. SummaryC3is beats SQZ Biotechnologies on 6 of the 11 factors compared between the two stocks. Get SQZ Biotechnologies News Delivered to You Automatically Sign up to receive the latest news and ratings for SQZ and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SQZ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SQZ vs. The Competition Export to ExcelMetricSQZ BiotechnologiesBiological Products IndustryMedical SectorNYSE ExchangeMarket Cap$826K$294.42M$5.78B$21.58BDividend YieldN/AN/A5.74%3.50%P/E Ratio-0.01N/A76.9430.17Price / Sales0.05423.92543.8877.26Price / CashN/A22.4437.1724.62Price / Book0.0110.1213.834.58Net Income-$79.46M-$115.81M$3.29B$1.00B7 Day PerformanceN/A1.55%1.57%1.52%1 Month PerformanceN/A7.33%6.87%5.96%1 Year PerformanceN/A-14.71%81.59%14.24% SQZ Biotechnologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SQZSQZ BiotechnologiesN/A$0.03flatN/AN/A$826K$18.16M-0.011,620CISSC3isN/A$2.07-1.9%N/A-86.0%$1.92M$42.30M-0.12N/AOPOceanPalN/A$1.16-1.3%N/A-96.7%$346K$25.70M-0.0260Positive NewsShort Interest ↓GVHGlobavend3.2701 of 5 stars$4.18-2.3%$80.00+1,813.9%-96.9%$293K$16.54M0.007Gap DownUSDPUSD PartnersN/A$0.01-1.7%N/A-51.1%$196K$72.32M-0.0190Gap UpAIRTPAir TN/A$19.15-0.5%N/A+10.0%$0.00$296.31M0.00500BLDEWBlade Air MobilityN/A$0.18+7.1%N/A-10.5%$0.00$254.34M0.00130Gap UpRABrookfield Real Assets Income FundN/A$13.56-0.2%N/A-1.1%$0.00$67.52M-123.23N/AEDRYEuroDry2.091 of 5 stars$11.06+1.1%N/A-35.3%$0.00$61.08M-2.13N/APositive NewsHSHPHimalaya ShippingN/A$8.23-0.2%N/A+10.0%$0.00$123.58M58.792Positive NewsDividend IncreaseEx-DividendGap UpIMPPPImperial PetroleumN/A$25.05-1.4%N/A-0.6%$0.00$127.68M0.00N/ADividend Cut Related Companies and Tools Related Companies CISS Competitors OP Competitors GVH Competitors USDP Competitors AIRTP Competitors BLDEW Competitors RA Competitors EDRY Competitors HSHP Competitors IMPPP Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:SQZ) was last updated on 9/19/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SQZ Biotechnologies Please log in to your account or sign up in order to add this asset to your watchlist. Share SQZ Biotechnologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SQZ Stock Alerts